A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.

Détails

Ressource 1Télécharger: 1402688_BIB_6912B8DACE03.pdf (469.59 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-SA 4.0
ID Serval
serval:BIB_6912B8DACE03
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
Périodique
The Journal of experimental medicine
Auteur(s)
Traversari C., van der Bruggen P., Luescher I.F., Lurquin C., Chomez P., Van Pel A., De Plaen E., Amar-Costesec A., Boon T.
ISSN
0022-1007
Statut éditorial
Publié
Date de publication
1992
Peer-reviewed
Oui
Volume
176
Numéro
5
Pages
1453-1457
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
We have reported the identification of human gene MAGE-1, which directs the expression of an antigen recognized on a melanoma by autologous cytolytic T lymphocytes (CTL). We show here that CTL directed against this antigen, which was named MZ2-E, recognize a nonapeptide encoded by the third exon of gene MAGE-1. The CTL also recognize this peptide when it is presented by mouse cells transfected with an HLA-A1 gene, confirming the association of antigen MZ2-E with the HLA-A1 molecule. Other members of the MAGE gene family do not code for the same peptide, suggesting that only MAGE-1 produces the antigen recognized by the anti-MZ2-E CTL. Our results open the possibility of immunizing HLA-A1 patients whose tumor expresses MAGE-1 either with the antigenic peptide or with autologous antigen-presenting cells pulsed with the peptide.
Mots-clé
Amino Acid Sequence, Antigens, Neoplasm/genetics, Base Sequence, HLA-A1 Antigen/immunology, Humans, Melanoma/immunology, Molecular Sequence Data, Oligopeptides/analysis, T-Lymphocytes, Cytotoxic/immunology
Pubmed
Web of science
Open Access
Oui
Création de la notice
28/01/2008 12:19
Dernière modification de la notice
20/08/2019 15:24
Données d'usage